Breaking down barriers to collaboration in vitiligo research

Meeting agenda:

- Welcome word by Iltefat Hamzavi , MD Henry Ford Hospital, Detroit, Michigan, USA
- Update from Vitiligo Global Issues Consensus Conference National reference center for rare skin diseases - Dr Khaled EZZEDINE, Department of Dermatology, Hôpital St-André, CHU de Bordeaux
- Vitiligo surgery - overview and barriers to collaboration by - Davinder Prasad – Head of Vitiligo Surgery panel, Post Graduate Institute for Medical Sciences, Chandigar India
- Experience with the first two cases of non-cultured melanocyte transfer for vitiligo in South Africa - N Raboobee, University of KZN, Durban, South Africa
- John Harris, Panel leader for Basic Science of Vitiligo What we know about vitiligo basic science – barriers to collaboration. MD University of Massachusetts Medical School, Worcester, MA, USA 

.

Abstracts presented: 

- Monitoring Treatment Outcomes in Vitiligo Non-Invasively Using Confocal Microscopy - Dr. Babar Rao

- CXCL10, an IFN-induced chemokine, is required for the development of depigmentation in a mouse model of vitiligo - Rashighi M, Agarwal P, Harris TH, Deng A, Hunter CA, and Harris JE - University of Massachusetts Medical School, Worcester, MA, USA, University of Pennsylvania, Philadelphia, PA, USA.

- Novel gene expression changes in the microenvironment of vitiligo lesional skin - Mingwan Su, Richard Yu, Xuejun Zhang, and Youwen Zhou - Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canada

- Abrar Qureishi, Panel leader Epidemiology - barriers to collaboration
Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. 

- Validation of a Vitiligo-Specific Health-Related Quality of Life (VitiQoL) Instrument - Roopal V. Kundu, MD - Department of Dermatology, Northwestern University, Chicago, IL, USA

- Co-morbidities associated with vitiligo: A 10-year retrospective study -
Vaneeta M Sheth, MD, Evie Guo, Abrar A Qureshi, MD/MPH Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. 

- Henry Lim, Henry Ford Hospital, Detroit Michigan – Panel leader clinical research ,patient advocacy and increasing resources for vitiligo research Increasing support for Vitiligo basic science, epidemiologic and clinical research. What are the barriers to collaboration?

- A Proof of Concept Study to Compare the Efficacy and Safety of Subcutaneous, Bioresorbable Afamelanotide Implants and Narrow-Band Ultraviolet B (NB-UVB) Light versus Narrow-Band Ultraviolet B (NB-UVB) Light Alone in the Treatment of Nonsegmental Vitiligo - Oma N. Agbai, M.D., Iltefat Hamzavi, M.D., Henry W. Lim, M.D., All authors affiliated with Henry Ford Hospital